US2012276564A1PendingUtilityA1
Luciferins
Est. expiryMar 2, 2027(~0.6 yrs left)· nominal 20-yr term from priority
Inventors:Stephen C. Miller
C07D 277/62C12Q 1/66C07D 277/68
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Novel luciferins, methods of making luciferins, and uses of the same are disclosed.
Claims
exact text as granted — not AI-modified1 . A method of imaging a sample, the method comprising:
obtaining a sample comprising a luciferase; contacting the sample with a compound of Structure (III) or (IV), or a salt or acid ester thereof:
wherein:
R 1 and R 2 are each independently H, provided that R 1 and R 2 are not both H, C 1-12 alkyl optionally substituted by an amino group, an amide group, an imine group, a hydroxyl group, a carboxylic acid group, an ester group, an anhydride group, an aldehyde group, a ketone group, an ether group, a thio-ester group, a thiol group, a thioether group, a phosphate group, a phosphonate group, a phosphine group, a phosphoramide group, an alkyl group, an alkenyl group, an alkynyl group, an aryl group, F, Cl, Br, I, or a near infrared fluorophore, optionally with a spacer; wherein
R 3 is H, OH, C 1-12 alkyl optionally substituted by an amino group, an amide group, an imine group, a hydroxyl group, a carboxylic acid group, an ester group, an anhydride group, an aldehyde group, a ketone group, an ether group, a thio-ester group, a thiol group, a thioether group, a phosphate group, a phosphonate group, a phosphine group, a phosphoramide group, an alkyl group, an alkenyl group, an alkynyl group, an aryl group, F, Cl, Br, I, or a near infrared fluorophore, optionally with a spacer; wherein
R 4 and R 5 are each independently H, OH, or C 1-6 alkyl optionally substituted by an amino group, an amide group, an imine group, a hydroxyl group, a carboxylic acid group, an ester group, an anhydride group, an aldehyde group, a ketone group, an ether group, a thio-ester group, a thiol group, a thioether group, a phosphate group, a phosphonate group, a phosphine group, a phosphoramide group, an alkyl group, an alkenyl group, an alkynyl group, an aryl group, F, Cl, Br, or I; wherein
R 6 and R 7 are each independently H, or C 1-8 alkyl optionally substituted by an amino group, an amide group, an imine group, a hydroxyl group, a carboxylic acid group, an ester group, an anhydride group, an aldehyde group, a ketone group, an ether group, a thio-ester group, a thiol group, a thioether group, a phosphate group, a phosphonate group, a phosphine group, a phosphoramide group, an alkyl group, an alkenyl group, an alkynyl group, an aryl group, F, Cl, Br, or I; wherein
R 1 , R 2 , R 3 , or R 5 together with one or more of its immediate neighbors define one or more 5, 6, or 7-membered rings; wherein
the rings optionally include one or more groups selected from: an amino group, an amide group, an imine group, a hydroxyl group, a carboxylic acid group, an ester group, an anhydride group, an aldehyde group, a ketone group, an ether group, a thio-ester group, a thiol group, a thioether group, a phosphate group, a phosphonate group, a phosphine group, a phosphoramide group, an alkyl group, an alkenyl group, an alkynyl, an aryl group, F, Cl, Br, and I; and wherein
the spacer is C 1-24 alkyl optionally substituted by one or more groups selected from: an amino group, an amide group, an imine group, a hydroxyl group, a carboxylic acid group, an ester group, an anhydride group, an aldehyde group, a ketone group, an ether group, a thio-ester group, a thiol group, a thioether group, a phosphate group, a phosphonate group, a phosphine group, a phosphoramide group, an alkyl group, an alkenyl group, an alkynyl, an aryl group, F, Cl, Br, and I; and
detecting bioluminescent emission from the sample.
2 . The method of claim 1 , wherein the spacer is a polymer fragment of a water-soluble polymer fragment.
3 . The method of claim 1 , wherein R 3 , R 4 , R 5 , R 6 and R 7 are each hydrogen, or an alkyl group having fewer than 4 carbon atoms.
4 . A method of imaging a sample, the method comprising:
obtaining a sample comprising a luciferase; contacting the sample with a compound of Structure (V), or salts or acid esters thereof:
wherein
R 4 is H, OH, or C 1-6 alkyl optionally substituted by an amino group, an amide group, an imine group, a hydroxyl group, a carboxylic acid group, an ester group, an anhydride group, an aldehyde group, a ketone group, an ether group, a thio-ester group, a thiol group, a thioether group, a phosphate group, a phosphonate group, a phosphine group, a phosphoramide group, an alkyl group, an alkenyl group, an alkynyl group, an aryl group, F, Cl, Br, or I; wherein
R 6 and R 7 are each independently H or C 1-8 alkyl optionally substituted by an amino group, an amide group, an imine group, a hydroxyl group, a carboxylic acid group, an ester group, an anhydride group, an aldehyde group, a ketone group, an ether group, a thio-ester group, a thiol group, a thioether group, a phosphate group, a phosphonate group, a phosphine group, a phosphoramide group, an alkyl group, an alkenyl group, an alkynyl group, an aryl group, F, Cl, Br, or I; wherein
R 1 and R 5 and R 2 and R 3 together with one or more of its immediate neighbors define one or more 5, 6, or 7-membered rings; and wherein
the rings optionally include one or more groups selected from: an amino group, an amide group, an imine group, a hydroxyl group, a carboxylic acid group, an ester group, an anhydride group, an aldehyde group, a ketone group, an ether group, a thio-ester group, a thiol group, a thioether group, a phosphate group, a phosphonate group, a phosphine group, a phosphoramide group, an alkyl group, an alkenyl group, an alkynyl, an aryl group, F, Cl, Br, and I; and detecting bioluminescent emission from the sample.
5 . The methods of claim 1 , wherein R 1 and/or R 2 are each C 1-12 alkyl linked to a near infrared fluorophore.
6 . The methods of claim 1 , wherein R 3 is C 1-12 alkyl linked to a near infrared fluorophore.
7 . The method of claim 1 , wherein the compounds are selected from:
8 . The method of claim 1 , wherein the luciferase has a mutation at Serine 347 to an amino acid with a smaller side chain.
9 . The method of claim 8 , wherein the luciferase has a mutation at Serine 347 to alanineCited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.